Cargando…
CRASH-2 Study of Tranexamic Acid to Treat Bleeding in Trauma Patients: A Controversy Fueled by Science and Social Media
This paper reviews the application of tranexamic acid, an antifibrinolytic, to trauma. CRASH-2, a large randomized controlled trial, was the first to show a reduction in mortality and recommend tranexamic acid use in bleeding trauma patients. However, this paper was not without controversy. Its pati...
Autores principales: | Binz, Sophia, McCollester, Jonathon, Thomas, Scott, Miller, Joseph, Pohlman, Timothy, Waxman, Dan, Shariff, Faisal, Tracy, Rebecca, Walsh, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576020/ https://www.ncbi.nlm.nih.gov/pubmed/26448897 http://dx.doi.org/10.1155/2015/874920 |
Ejemplares similares
-
Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
por: Walsh, Mark, et al.
Publicado: (2016) -
Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial
por: Roberts, Ian, et al.
Publicado: (2014) -
Cost-Effectiveness Analysis of Administering Tranexamic Acid to
Bleeding Trauma Patients Using Evidence from the CRASH-2 Trial
por: Guerriero, Carla, et al.
Publicado: (2011) -
Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms
por: Roberts, Ian, et al.
Publicado: (2017) -
Draft Genome Sequence of a Mycobacterium porcinum Strain Isolated from a Pet Cat with Atypical Mycobacterial Panniculitis
por: Mannion, Anthony, et al.
Publicado: (2020)